SNU-2535Homo sapiens (Human)Cancer cell line

AI Summary

No AI-generated summary available for this cell line.

Basic Information

Database IDCVCL_R756
SpeciesHomo sapiens (Human)
Tissue SourcePleural effusion[UBERON:UBERON_0000175]

Donor Information

Age57
Age CategoryAdult
SexFemale

Disease Information

DiseaseLung adenocarcinoma
LineageLung
SubtypeLung Adenocarcinoma
OncoTree CodeLUAD

DepMap Information

Source TypeKCLB
Source IDACH-002531_source

Known Sequence Variations

TypeGene/ProteinDescriptionZygosityNoteSource
MutationSimpleALKp.Gly1269Ala (c.3806G>C)Heterozygous-Unknown, PubMed=35852680, CelloPub=CLPUB00546
Gene fusionALKEML4-ALK-E6A20 v3 fusionPubMed=35933914, PubMed=31882684

Haplotype Information (STR Profile)

Short Tandem Repeat (STR) profile for cell line authentication.

Amelogenin
X
CSF1PO
11
D13S317
9,11
D16S539
9,11
D18S51
15
D19S433
10.2,14
D21S11
28,29
D2S1338
20,23
D3S1358
14,15
D5S818
10,12
D7S820
11
D8S1179
13,15
FGA
24,27
TH01
7,9.3
TPOX
11
vWA
16,17
Gene Expression Profile
Gene expression levels and statistical distribution
Loading cohorts...
Full DepMap dataset with combined data across cell lines

Loading gene expression data...

Publications

Establishment of an acquired lorlatinib-resistant cell line of non-small cell lung cancer and its mediated resistance mechanism.

Zhang W.-M.

Clin. Transl. Oncol. 24:2231-2240(2022).

Heterogeneity of genetic changes associated with acquired crizotinib resistance in ALK-rearranged lung cancer.

Chung D.H., Heo D.S.

J. Thorac. Oncol. 8:415-422(2013).